vaccine

    • Hungary to offer third Covid-19 vaccine dose

      Hungary to offer third Covid-19 vaccine dose

      Starting from 1 August, Hungary will offer the option of taking a third dose of a Covid-19 vaccine and will make coronavirus vaccines mandatory for all healthcare workers, PM Viktor Orban told state radio on Friday. He pointed out that doctors will decide which vaccine people should take as a third dose, and it should come at least 4 months after the second shot, unless doctors advise otherwise.

      60
    • Young Greeks given cash to get vaccinated

      Young Greeks given cash to get vaccinated

      Greece will give young adults €150 to get vaccinated, PM Kyriakos Mitsotakis said Monday. Starting July 15, Greek citizens under 26 would be eligible for the credit in a digital wallet after receiving the first dose of their Covid-19 vaccine. The effort is a part of Athens' two-tier access policy over the summer.

      64
    • Novavax Covid-19 vaccine more than 90% effective

      Novavax Covid-19 vaccine more than 90% effective

      Novavax vaccine against Covid-19 proved more than 90% effective against a variety of virus variants, the company reported on Monday. The results came from its US-based clinical trial, news wires reported. The study of nearly 30,000 volunteers puts Novavax on track to file for emergency authorisation in the US and elsewhere in the third quarter of 2021.

      384
    • Social media influencers get offer to spread false news on vaccine

      Social media influencers get offer to spread false news on vaccine

      Social media influencers in France with hundreds of thousands of followers say a mysterious advertising agency offered to pay them if they agreed to smear Pfizer’s Covid-19 vaccine with negative fake stories. The smear effort drew a withering response from French Health Minister Olivier Veran. “It’s pathetic, it’s dangerous, it’s irresponsible and it doesn’t work,” he said.

      81
    • Sanofi/GSK Covid-19 jabs on the verge of EU approval

      Sanofi/GSK Covid-19 jabs on the verge of EU approval

      New Covid-19 vaccine is on the verge of EU approval as French-English consortium Sanofi/ GlaxoSmithKline reported very high efficiency and good tolerability of its jabs, Reuters reported. The vaccine proved a robust immune response in early trials. The study is now scheduled for a late trial that precedes granting an approval for usage.

      91
    • J&J awards CEO with a multi-million pay plan

      J&J awards CEO with a multi-million pay plan

      The shareholders at the pharmaceutical company Johnson & Johnson decided to grant approval on a non-binding advisory basis to a generous pay plan related to Chief Executive Alex Gorsky, Reuters reported. The vote of the stockholders paves the way for a $29.6 million pay plan for 2020. J&J posted substantial revenue from its Covid-19 vaccine but at end-2020 the efficiency of the jabs and their safety for usage were put under additional monitoring both in EU and US. A potential approval for usage will significantly increase the profit outlook for the company.

      412